Koers Bausch Health Companies Inc Toronto S.E.
Aandelen
CA91911K1021
Farmaceutische producten
Omzet 2024 * | 9,39 mld. 12,83 mld. 8,78 mld. | Omzet 2025 * | 9,45 mld. 12,92 mld. 8,84 mld. | Marktkapitalisatie | 3,19 mld. 4,37 mld. 2,99 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 336 mln. 459 mln. 314 mln. | Nettowinst (verlies) 2025 * | 381 mln. 521 mln. 356 mln. | EV/omzet 2024 * | 2,46 x |
Nettoschuld 2024 * | 19,91 mld. 27,21 mld. 18,62 mld. | Nettoschuld 2025 * | 18,33 mld. 25,05 mld. 17,14 mld. | EV/omzet 2025 * | 2,28 x |
K/w-verhouding 2024 * |
13,2
x | K/w-verhouding 2025 * |
8,46
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 97,66% |
Recentste transcriptie over Bausch Health Companies Inc
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Thomas Appio
CEO | Chief Executive Officer | 61 | - |
John Barresi
DFI | Director of Finance/CFO | 51 | 24-05-22 |
Chief Operating Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Robert Power
BRD | Director/Board Member | 67 | 01-08-08 |
John Paulson
CHM | Chairman | 68 | 01-06-17 |
Steven Miller
BRD | Director/Board Member | 35 | 17-03-21 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,83% | 661 mld. | |
+27,00% | 566 mld. | |
-6,76% | 352 mld. | |
+20,34% | 332 mld. | |
+3,00% | 283 mld. | |
+13,09% | 231 mld. | |
+5,46% | 200 mld. | |
-9,61% | 195 mld. | |
-6,26% | 145 mld. |